|
 |
| On the cover: The sun not only breeds all life, but also brings inexhaustible clean energy to the earth. The development of flexible photovoltaic technology, represented by flexible perovskite solar cells, frees the energy production from the constraints of traditional centralized photovoltaic application scenarios. From spacecraft and curved photovoltaics to wearable devices and IoT sensors, the combination of flexible photovoltaics and advanced technology will realize a more flexible, convenient and imaginative collection and utilization of solar energy, contributing to a more intelligent and sustainable human society. |
|
|
| Add comment (English only) |
|
|
|
|
|
| Position: Home > issue > November 08, 2022 Volume 3, Issue 6 |
|
|
|
| The First Chinese Oral Anti-COVID-19 Drug Azvudine Launched |
Category: News & Buzz Download:  PDF  Figure  Endnote |
| Author: Bin Yu, Junbiao Chang |
|
|
Mechanism of Azvudine against SARS-CoV-2
Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) at the end of 2019, thousands of SARS-CoV-2 mutations have been increasingly observed. The virus epidemic has posed unprecedented challenges to global public health. As of September 6, 2022, over 603 million confirmed cases and about 6.48 million deaths worldwide have been reported to the World Health Organization (WHO). The development of novel antivirals capable of treating SARS-CoV-2 infections has been a central focus of current research. To cope with the current novel coronavirus pneumonia (COVID-19) epidemic, the National Medical Products Administration (NMPA) granted conditional authorization for Azvudine developed by us to be used to treat COVID-19 on July 25, 2022, being the first domestic oral antiviral agent approved in China.
|
|
|
|
TheInnovation´´ÐÂ
TheInnovation´´ÐÂ
The_Innovation
office@the-innovation.org
Official£º